Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Femoral nerve block in patients with suspected hip fracture
2008-004303-59Phase 4Active
- Sponsor
- Region Örebro län
- Start
- Jul 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine in hip fracture, sponsored by Region Örebro län. Primary endpoint: Pain reduction. Started Jul 2008; status: active.
02
Drugs
ropivacaine
03
Conditions
hip fracture
Beyond the preview
Go deeper on 2008-004303-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004303-59.